SEC Form 4 · accession 0001104659-15-012650
NPS PHARMACEUTICALS INC · NPSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter G Tombros
Director
Period of report
Feb 12, 2015
Accepted (ET)
Feb 20, 2015 · 4:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Feb 12, 2015 | A | 3,816 | A | — | — | Common Stock | 3,816 | 3,816 | D |
Explanation of responses
- F1Each Restricted Stock Unit was awarded under NPS Pharmaceuticals Inc.'s (the "Issuer") amended and restated 2005 Omnibus Incentive Plan and represents a contingent right to receive one share of the Issuer's common stock.
- F2One hundred percent of the Restricted Stock Units will vest on the first anniversary of the date of grant. Vested shares will be delivered to the reporting person as soon as administratively practicable following the vesting of the Restricted Stock Units.